• Study on PBP1510 and Gemcitabine for Patients with Advanced Pancreatic Cancer After Previous Chemotherapy

    Recruiting

    2 1 1
    Spain
  • Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Bulgaria Czechia Italy Poland Romania Slovakia
  • Study of Catheter-Directed Thrombolysis Using Alteplase for Treatment of Intermediate-High Risk Acute Pulmonary Embolism

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • Study on Improving Bone Health in Children with Cystic Fibrosis Using Cholecalciferol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • Study on Changes in [18F]F-AraG Uptake After Radiotherapy in Patients with Non-Small Cell Lung Cancer, Melanoma, Breast Cancer, and Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Dominant or Mixed-Type Irritable Bowel Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    Germany
  • Study on the Safety and Effectiveness of VX-880 for Patients with Type 1 Diabetes and Severe Low Blood Sugar Awareness

    Recruiting

    4 1 1
    Investigated Drugs:
    France Germany Italy The Netherlands Norway
  • Study on Tabelecleucel for Patients with Epstein-Barr Virus-Associated Diseases

    Recruiting

    2 1 1
    Investigated Drugs:
    Austria Belgium France Italy Spain
  • Study Comparing Lithium and Cariprazine for Treating Bipolar Depression in Patients with Bipolar Type 1 or 2 During a Depressive Episode

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Study of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Belgium France Hungary Ireland Italy Portugal +1

powered by